Ilan Irony | Deputy Director Division Of Clinical Evaluation And Pharmacology, Center for Biologics Evaluation and Research (CBER)
Food and Drug Administration (FDA)

Ilan Irony, Deputy Director Division Of Clinical Evaluation And Pharmacology, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA)

Appearances:



World Orphan Drug Congress USA 2019 - Day 1 @ 16:20

FDA gene therapy draft guidance documents – disease specific guidances and long-term follow up

last published: 20/Mar/19 21:45 GMT

back to speakers